| abstract |
The present invention provides synthetic compounds, which are derivatives of the breast cancer antigen her-2 (amino acid residues 774 to 782), antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds, and immune effector cells raised in response to presentation of these epitodes. The invention further provides methods for inducing an immune response and administering immunotherapy to a subject by delivering the compositions of the invention. |